Lucas W. Buchanan - 09 Nov 2022 Form 4 Insider Report for Silk Road Medical Inc

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
09 Nov 2022
Net transactions value
-$1,210,000
Form type
4
Filing time
14 Nov 2022, 17:24:11 UTC
Previous filing
05 Oct 2022
Next filing
15 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $320 +200 +0.11% $1.60* 176,727 09 Nov 2022 Direct F1
transaction SILK Common Stock Sale $10,000 -200 -0.11% $50.00 176,527 09 Nov 2022 Direct F1
transaction SILK Common Stock Options Exercise $39,680 +24,800 +14% $1.60* 201,327 11 Nov 2022 Direct F1
transaction SILK Common Stock Sale $1,240,000 -24,800 -12% $50.00 176,527 11 Nov 2022 Direct F1
holding SILK Common Stock 13,518 09 Nov 2022 Buchanan Grandchildren's Irrevocable Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -200 -0.15% $0.000000 130,209 09 Nov 2022 Common Stock 200 $1.60 Direct F1, F3
transaction SILK Option (right to buy) Options Exercise $0 -24,800 -19% $0.000000 105,409 11 Nov 2022 Common Stock 24,800 $1.60 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 13, 2022.
F2 These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F3 All of the shares subject to this option are fully vested and exercisable as of the date hereof.